4D Molecular Therapeutics (FDMT) Invested Capital (2025 - 2026)
4D Molecular Therapeutics' Invested Capital came in at $427.25 million for Q2 2026.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Invested Capital (2025 - 2026) Analysis & Trends
For FY2025, 4D Molecular Therapeutics' Invested Capital was $505.66 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | 4D Molecular Therapeutics | 875.59 Mn | -584.35 Mn | - | 427.25 Mn |
API Access
4D Molecular Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();